Development,validation, and implementation of capillary gel electrophoresis as a replacement for SDS‐PAGE for purity analysis of IgG2 mAbs |
| |
Authors: | Nathan A. Lacher Rachel K. Roberts Yan He Holly Cargill Katrina M. Kearns Heidi Holovics Margaret N. Ruesch |
| |
Affiliation: | Analytical R&D, Pfizer BioTherapeutics R&D, Chesterfield, MO, USA |
| |
Abstract: | Capillary gel electrophoresis (CGE) methods with UV detection were developed for reduced and non‐reduced mAb analysis. These methods can be used to evaluate mAb purity, offering more reproducible quantitation compared with that of traditional SDS‐PAGE methods. These CGE methods have been utilized as platform technology for bioprocess development, formulation development, mAb characterization, drug substance/drug product release testing as well as a required methodology for stability testing. We have found these CGE methods to be applicable across a platform of mAbs in preclinical and clinical development, with the majority of mAbs requiring no modification to the method conditions. This methodology has been ICH validated and transferred to several supporting organizations. The data presented herein describes the development of CGE methodology, platform application to mAb purity analysis, ICH validation, reliability metrics, and considerations on technology enhancement for improved performance and throughput. |
| |
Keywords: | Antibody IgG2 CE Qualification |
|
|